Labs in Court: Lab Settles Kickback Allegations for $5.9M
Two companies settle kickback and FCA-related claims, a qui tam case is tossed, and a lab tech loses a workplace harassment case.
Diagnostic Testing and Emerging Technologies
LAB COMPLIANCE ADVISOR
LABORATORY INDUSTRY REPORT
NATIONAL LAB REPORTER
Two companies settle kickback and FCA-related claims, a qui tam case is tossed, and a lab tech loses a workplace harassment case.
In this month’s Labs in Court roundup, a medical device company and genetic testing company each win key victories.
Key cases over the last month include a CGx testing kickback scheme, false billing, and violations of a non-compete clause and HIPAA.
Key cases over the past month were the usual FCA-related fare, apart from a dismissed sex discrimination case.
In this month’s roundup of key lab-related cases, a bizarre twist in the Theranos saga leads to a slim chance of a mistrial.
This month’s key lab cases involve false billing of urine drug and PGx tests and two lawsuits that were tossed.
In this Labs in Court monthly roundup, the Texas-based pathology lab was accused of falsely billing Medicare for unnecessary tests on biopsy specimens.
In this month’s Labs in Court roundup, BioReference pays big to settle kickback allegations, among several other kickback-related cases.
In this month’s Labs in Court roundup, Arrayit’s former president loses his bid to have EKRA charges dismissed, and more.
Legal team’s bid to dismiss part of CMS inspector’s testimony as hearsay is denied by the Northern District of California federal court.
Of this month’s four Labs in Court cases, three involved kickbacks resulting in widely varying penalties.